|
| Press Releases |
|
 |
|
| Friday, March 24, 2023 |
|
|
医思健康与诺辉健康达成战略合作 共同推动「宫证清」在港上市 |
| 医思健康（2138.HK）与诺辉健康（6606.HK）今日举行签约仪式，双方达成独家战略合作，未来将全面整合双方的优质资源，共同推动宫证清在中国香港的注册上市、分销及市场推广，以居家早筛助力宫颈癌预防医学服务的普及，加速实现宫颈癌的有效预防。 more info >> |
|
|
醫思健康與諾輝健康達成戰略合作 共同推動「宮證清」在港上市 |
| 醫思健康（2138.HK）與諾輝健康（6606.HK）今日舉行簽約儀式，雙方達成獨家戰略合作，未來將全面整合雙方的優質資源，共同推動宮證清在中國香港的註冊上市、分銷及市場推廣，以居家早篩助力宮頸癌預防醫學服務的普及，加速實現宮頸癌的有效預防。 more info >> |
|
|
EC Healthcare Collaborates with New Horizon Health to form Strategic Partnership To Jointly Launch CerviClear in Hong Kong |
| EC Healthcare (2138.HK) and New Horizon Health (6606.HK) host ceremony today to form an exclusive strategic partnership. Both parties will consolidate the resources to empower the launching, distribution, and promotion of CerviClear in Hong Kong. more info >> |
|
| Friday, August 19, 2022 |
|
|
New Horizon Health Announced 2022 Interim Report: Revenue Up 414% YoY, Gross Margin Climbs to 82% |
New Horizon Health (6606.HK), China's leading biotechnology company for early cancer screening, announced its half-year results for the year ended June 30, 2022 today.
more info >> |
|
| Friday, March 18, 2022 |
|
|
诺辉健康发布2021年报：营收同比增长202%，毛利率攀升至72.7% |
| 中国领先的癌症早筛生物高科技公司诺辉健康（6606.HK）今日发布2021年截至12月31日的年度业绩报告。 more info >> |
|
|
諾輝健康發佈2021年報：營收同比增長202%，毛利率攀升至72.7% |
| 中國領先的癌症早篩生物高科技公司諾輝健康（6606.HK）今日發佈2021年截至12月31日的年度業績報告。 more info >> |
|
| Saturday, August 21, 2021 |
|
|
New Horizon Health Announces 2021 Interim Results: Revenue Increases 317% Year-on-year, Gross Profit Margin Climbs to 56.2% |
| New Horizon Health (6606.HK) (the "Company"), the first public listed cancer screening company in China, has today announced its financial report for the first half year ended 30 June 2021. more info >> |
|
| Friday, August 20, 2021 |
|
|
諾輝健康發佈2021年中報業績：營收同比增長317%，毛利率攀升至56.2% |
| 中國首家專注於癌症早篩的生物高科技公司諾輝健康（6606.HK）今日發佈2021年上半年截至6月30日的財務報告。 more info >> |
|
| Monday, February 8, 2021 |
|
|
基因检测行业的未来明珠获资本巨头鼎力相助 诺辉健康潜力十足 |
| 开年至今，港股市场氛围热烈，康希诺生物、荣昌生物、康方生物等生物科技公司涨势喜人。由于新冠肺炎疫情仍在世界范围扩散，促使医疗需求急剧上升，此类生物科技领域的「18A上市公司」自2020年以来愈发受到市场关注，股价表现亮眼。 more info >> |
|
|
基因檢測行業的未來明珠獲資本巨頭鼎力相助 諾輝健康潛力十足 |
| 開年至今，港股市場氛圍熱烈，康希諾生物、榮昌生物、康方生物等生物科技公司漲勢喜人。由於新冠肺炎疫情仍在世界範圍擴散，促使醫療需求急劇上升，此類生物科技領域的「18A上市公司」自2020年以來愈發受到市場關注，股價表現亮眼。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
GA-ASI Announces Investment in Dutch Technology Innovator Arceon
Jun 27, 2025 01:00 HKT/SGT
|
|
|
GA-ASI 宣布投資荷蘭科技創新公司 Arceon
Jun 27, 2025 01:00 HKT/SGT
|
|
|
On Its Centennial: The Occasion of Replacing the Kiswa of the Noble Kaaba Embodies the Kingdom of Saudi Arabia's Enduring Care for the Two Holy Mosques
Jun 26, 2025 23:46 HKT/SGT
|
|
|
IBI Announces 23-Fold Surge in Net Profit for FY2025
Jun 26, 2025 22:37 HKT/SGT
|
|
|
IBI公佈2025財年淨利潤大幅增長23倍 在充滿挑戰的環境中實現強勁業績
Jun 26, 2025 22:24 HKT/SGT
|
|
|
IBI公布2025财年净利润大幅增长23倍 在充满挑战的环境中实现强劲业绩
Jun 26, 2025 22:08 HKT/SGT
|
|
|
Wasion Wins Three Major Smart Power Meter Contracts In Emerging Overseas Markets, Total Contract Value Exceeds HK$940 million
Jun 26, 2025 20:58 HKT/SGT
|
|
|
威勝控股集團成功於海外新興市場奪得三項大型智能電表合約 總價值逾9.4億港元
Jun 26, 2025 20:46 HKT/SGT
|
|
|
威胜控股集团成功于海外新兴市场夺得三项大型智能电表合约 总价值逾9.4亿港元
Jun 26, 2025 20:33 HKT/SGT
|
|
|
AEON Credit Reported Rebound Growth in 1QFY2025/26, Net Profit Up 31.3% to HK$109.3 million
Jun 26, 2025 21:01 JST
|
|
|
AEON信貸財務於二零二五/二六財年第一季度錄得反彈增長 純利增31.3%至1.093億港元
Jun 26, 2025 19:54 HKT/SGT
|
|
|
AEON信贷财务于二零二五/二六财年第一季度录得反弹增长 纯利增31.3%至1.093亿港元
Jun 26, 2025 19:41 HKT/SGT
|
|
|
Regina Miracle FY25 Net Profit Up by 28.4% to HK$180 Million
Jun 26, 2025 19:19 HKT/SGT
|
|
|
維珍妮25財年純利增28.4%至1.8億港元 末期息每股4.3港仙
Jun 26, 2025 19:05 HKT/SGT
|
|
|
维珍妮25财年纯利增28.4%至1.8亿港元 末期息每股4.3港仙
Jun 26, 2025 18:36 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
